Cargando…
FRI311 GnRH Agonist Induced Pituitary Apoplexy In A Patient With Gonadotropinoma
Disclosure: I. Madahar: None. S. Khan: None. L. Hergenroeder: None. B. Skaff: None. A. Haider: None. Introduction: GnRH therapy is commonly employed in patients with advanced prostate cancer. It acts as an agonist that binds to pituitary GnRH receptors. It acts via desensitization, downregulating FS...
Autores principales: | Madahar, Inderpreet, Khan, Salwa, Hergenroeder, Laurel, Skaff, Brianna, Haider, Adnan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555747/ http://dx.doi.org/10.1210/jendso/bvad114.1246 |
Ejemplares similares
-
FRI312 Diplopia And Headache After Treatment With GnRH Agonist
por: Zakkar, Adam A, et al.
Publicado: (2023) -
FRI284 The GnRH Pulse Generator Activity In Mouse Models Of Polycystic Ovary Syndrome
por: Zhou, Ziyue, et al.
Publicado: (2023) -
Polyciliation of GnRH Neurons in Vivo and in Vitro
por: Brewer, Kathryn M, et al.
Publicado: (2021) -
FRI283 Fragile X Gene Mutations Alter GnRH Neuron And Ovarian Innervation With Consequences On Reproductive Function
por: Villa, Pedro A, et al.
Publicado: (2023) -
FRI336 A Case Of Pituitary Apoplexy In Late Pregnancy
por: Abdelrahman, Houda, et al.
Publicado: (2023)